Skip to content

Clinical trials

Phase 1 Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 1 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20073
20081
20103
20141
20152
20171
20181
20192
20211
20221
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Withdrawn2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Luye Pharma Group Ltd.3
National Institute of Mental Health (NIMH)3
Mclean Hospital2
Soterix Medical2
Janssen Research & Development, LLC1
Medical University of South Carolina1
Minneapolis Veterans Affairs Medical Center1
Northstar Neuroscience1
Teva Pharmaceuticals USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder23
Major Depressive Disorder9
Depressive Disorder, Treatment-Resistant5
Mental Disorders5
Mood Disorders5
Anxiety Disorders4
Bipolar Disorder3
Psychotic Disorders2
Stress Disorders, Post-Traumatic2
Stress Disorders, Traumatic2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.